Taiwan FDA registration 89b439db09996b62f69c05edf5a067fd

Nofafer Human Anti-Toxoplasmin Immunoglobulin M Enzyme Immunoassay Set

TW: 諾法鐵人類抗弓漿蟲免疫球蛋白M酵素免疫分析套組

Taiwan·Risk Class 2·GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH·Registered Nov 06, 2006 – Nov 06, 2026Active

Registration details

Analysis ID: 89b439db09996b62f69c05edf5a067fd
Customs Code: DHA00601759901

Company information

Manufacturer: GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH
Manufacturer Country: Germany
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: Qualitative detection of antibodies to the M typing of anti-toxoplasma immunoglobulin in human serum.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3780 弓漿蟲血清試劑
Import Information: import

Dates and status

Registration Date: Nov 06, 2006
Expiry Date: Nov 06, 2026

About this record

Access comprehensive regulatory information for Nofafer Human Anti-Toxoplasmin Immunoglobulin M Enzyme Immunoassay Set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 89b439db09996b62f69c05edf5a067fd and manufactured by GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.